Company Analysis

TherapeuticsMD, Inc. (TXMD)

Nasdaq: TXMD · Pharmaceutical Preparations · Boca Raton, FL · filing with the SEC since 1995
Grade5.5
◀ Past 4.3● Present 6.7▶ Future 5.2
1 est.

Who runs TherapeuticsMD, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Walker Marlan D
Chief Executive Officer. First filing Aug 2020, latest Nov 5, 2025, 7 filings in all.
Officers reporting now
2
of 4 people with a filing in the last fifteen months
Directors reporting now
2
26 people on the record since 2011
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Thompson Tommy GChairmanMay 2012Dec 29, 2025none
Walker Marlan DChief Executive OfficerAug 2020Nov 5, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Collins Cooper C.directorMar 2012Nov 5, 2025none
Naughton Gail KdirectorMar 2020Nov 5, 2025none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TXMD · research, not advice